Full-Time

Director – IT Business Solutions Partner

Supply Chain

Posted on 9/25/2024

BridgeBio

BridgeBio

501-1,000 employees

Develops medicines for genetic diseases

Biotechnology

Compensation Overview

$210k - $255kAnnually

Senior, Expert

Remote in USA

Category
Lab & Research
Interdisciplinary Research
Life Sciences
Required Skills
Management
SAP Products
Requirements
  • 7-10 years of experience in IT management, with a strong background in life sciences, supply chain systems, and regulatory environments
  • Deep understanding of SAP S/4HANA, TraceLink, and master data management
  • Experience with integrating SAP with FICO is a plus
  • Well-versed in GxP, SOX, GDPR, and other regulatory standards
  • Experience leading teams through compliance audits
  • Passion for leveraging technology to solve complex business challenges
  • Proven track record of successfully leading large-scale IT projects, meeting timelines, and managing budgets
  • Collaborative leader who fosters an inclusive, innovative team culture and enjoys mentoring and developing talent
Responsibilities
  • Develop and execute a technology roadmap that aligns with the business strategy for the supply chain, focusing on scalability, regulatory compliance, and operational efficiency
  • Oversee the management and optimization of key supply chain platforms, including SAP S/4HANA, TraceLink, and related applications
  • Ensure that all supply chain systems meet global regulatory standards (e.g., DSCSA, EU FMD, Brazil Anvisa) and maintain compliance with GxP, SOX, GDPR, and other critical frameworks
  • Drive continuous improvement initiatives across supply chain processes by leveraging technology to enhance productivity, reduce costs, and improve accuracy
  • Manage relationships with external service providers, ensuring service level agreements (SLAs) are met and operations run smoothly
  • Partner with key stakeholders from Supply Chain, Quality, and Regulatory teams to define requirements, develop solutions, and support new business initiatives
  • Lead the design, implementation, and delivery of supply chain IT projects, ensuring they are completed on time, within scope, and on budget
  • Collaborate with internal and external auditors to maintain high standards of system security and regulatory compliance
  • Mentor and lead a team of IT professionals, fostering a culture of collaboration, accountability, and innovation

BridgeBio Pharma develops medicines specifically for genetic diseases, focusing on conditions with well-understood genetic causes. The company uses a decentralized subsidiary model, allowing each subsidiary to concentrate on therapies for specific diseases while sharing central resources. This structure enhances efficiency and enables the advancement of multiple drug programs at once. BridgeBio utilizes advancements in genome sequencing and molecular biology to identify and develop effective treatments. Their goal is to create significant therapeutic improvements by targeting diseases at their genetic source. With over 15 drug programs aimed at 20 different genetic diseases, BridgeBio aims to reduce the time it takes to bring treatments to market. The company promotes a culture of independent thinking and transparency, which supports quick, data-driven decision-making.

Company Stage

IPO

Total Funding

$704.4M

Headquarters

Palo Alto, California

Founded

2014

Growth & Insights
Headcount

6 month growth

20%

1 year growth

52%

2 year growth

101%
Simplify Jobs

Simplify's Take

What believers are saying

  • Partnership with PANTHERx Rare ensures strategic patient access to therapies.
  • Recent investments indicate strong financial backing and confidence in BridgeBio.
  • Launch of BridgeBio Oncology Therapeutics expands into precision oncology with $200m funding.

What critics are saying

  • Alnylam's Amvuttra poses competitive pressure on BridgeBio's Attruby.
  • KRAS inhibitors face significant scientific and clinical hurdles.
  • Decentralized model may challenge cohesive strategic direction and resource allocation.

What makes BridgeBio unique

  • BridgeBio employs a decentralized subsidiary model for rapid drug development.
  • Focus on genetic diseases with well-understood causes allows targeted therapeutic interventions.
  • Innovative use of genome sequencing and molecular biology for personalized medicine.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE